Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve the Standalone and Consolidated ....
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has informed BSE that its Board of Directors will meet on 13th November 2025. The main agenda is to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter and half year ended 30th September 2025 (Q2 FY26). This is a routine regulatory filing under SEBI Listing Regulations ahead of the earnings announcement. No financial figures or other business items have been disclosed in this notice.
This is a standard advance notice with no new information for shareholders. Investors should watch for the actual results on or after 13th November to assess the company's Q2 performance.